Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AVR compared with OKUR: revenue, margins and what each company keeps, and the suppliers and customers both name
AVR
Anteris Technologies Global Corp.
Change
Mkt cap
Revenue
Revenue
OKUR
OnKure Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AVR
Anteris Technologies Global Corp.
vs
OKUR
OnKure Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AVR, solid
OKUR, dashed
Supply-chain overlap
Revenue flow
AVR: latest quarter is a loss; flow not drawable. OKUR: latest quarter not drawable.
Method
›
AVR
Anteris Technologies Global Corp.
Change
6.30
▼
−1.81%
· post 6.30
Mkt cap
$615.0M
Revenue
$1M
Q2 FY26
Revenue
$2M
FY25
OKUR
OnKure Therapeutics, Inc.
Change
2.63
▲
+0.50%
· post 2.63
Closed
Oct 30 '26
Mkt cap
$106.1M
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
AVR
Anteris Technologies Global Corp.
vs
OKUR
OnKure Therapeutics, Inc.
6.30
▼
−1.81%
post 6.30
Price
2.63
▲
+0.50%
post 2.63
$615.0M
Mkt cap
$106.1M
Q2 FY26
$1M
Revenue
—
FY25
$2M
Revenue
—
Change
Change
AVR
6.30
▼
−1.81%
vs
OKUR
2.63
▲
+0.50%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AVR
2
—
4C
unlisted
customer
—
LeMaitre Vascular
unlisted
customer
Shared
0
No shared counterparties.
Only OKUR
2
—
PharmaBlock Sciences (Nanjing)
unlisted
supplier
—
STA Pharmaceutical Hong Kong
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR